Aktiesnakken — Juni 2012
-
derfor siger misset stadig de vil starte phase III i bladder og måske Ovarian i år
-
og det har hele tiden været planen med CUP studiet. at bruge det som proof of concept studiet for om BelCaP virker mod solide tumorer
-
det er det jeg gerne vil vide på CC - om Topo mener at resultaterne viser at der er proof of concept
-
ja vi skal gerne bliver lidt klogere på cc. Men cup er i hvert fald en ommer i bedste fald
-
Sidder du og trykker F5 hele tiden på topo website. De oploaer powerpoint præsentation forud for cc
-
smider du den her straks du ser den

-
den der købte i :,06 vil jeg foreslå at tage profit
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind


så kunne man nå at sælge uden hvis PFS er under 20...